SOA leads from the front in COVID battle
2100 beds, 157 ICU beds, plasma therapy, human trial of vaccine.
2100 beds, 157 ICU beds, plasma therapy, human trial of vaccine.
The Phase 3 trial will recruit 30,000 participants in the US, with half to receive the vaccine at 100 microgram dose levels, and the other half to receive a placebo.
